Kyung Dong Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of A011040?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	162,574	0.603%
Institutions	272,051	1.01%
Employee Share Scheme	1,160,000	4.31%
Company Controlled Foundation	1,518,749	5.64%
Individual Insiders	11,459,746	42.5%
General Public	12,368,650	45.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 21 shareholders own 54.09% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
38.3%	Gi-Sung Ryu	10,311,304	₩65.3b	0.83%	no data
5.64%	Kyung Dong Songcheon Foundation, Endowment Arm	1,518,749	₩9.6b	0%	no data
4.31%	Kyung Dong Labor Welfare Fund	1,160,000	₩7.3b	0%	no data
1.36%	Deok-Hee Ryu	367,700	₩2.3b	2.74%	no data
0.89%	Gi-Cheol Nam	238,600	₩1.5b	0%	no data
0.82%	Dimensional Fund Advisors LP	220,625	₩1.4b	-5.82%	no data
0.77%	Sang-Wook Jung	208,000	₩1.3b	0%	no data
0.46%	Rph Korea Co., Ltd.	123,800	₩783.7m	0%	no data
0.26%	Hyeon-Seok Ryu	70,000	₩443.1m	0%	no data
0.26%	Ji-Seok Ryu	70,000	₩443.1m	0%	no data
0.26%	Jun-Seok Ryu	70,000	₩443.1m	0%	no data
0.13%	Kyunghun Kim	35,000	₩221.6m	0%	no data
0.13%	Mirae Asset Global Investments Co., Ltd.	34,834	₩220.5m	0%	no data
0.11%	Byung-Seok Lee	30,000	₩189.9m	0%	no data
0.093%	Jong-Sik Park	25,000	₩158.2m	0%	no data
0.093%	Young-chan Kim	25,000	₩158.2m	0%	no data
0.074%	Jc Health Care Co. Ltd	20,000	₩126.6m	0%	no data
0.07%	Daeil Yang Hang Co. Ltd	18,774	₩118.8m	0%	no data
0.06%	KB Asset Management Co., Ltd.	16,260	₩102.9m	0%	no data
0.034%	Suk-Bum Kim	9,142	₩57.9m	28%	no data
0.0012%	Invesco Capital Management LLC	332	₩2.1m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 20:55
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kyung Dong Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hong-Sik Jeong	LS Securities Co., Ltd.
Tae Gi Ha	SK Securities Co., Ltd.